100 related articles for article (PubMed ID: 6150053)
21. Evaluation of TBII activity in untreated Graves' disease using solubilised thyroid membranes.
Taylor JJ; Young ET; Holcombe M; Kendall-Taylor P
Ann Clin Biochem; 1985 Jul; 22 ( Pt 4)():366-70. PubMed ID: 2864013
[TBL] [Abstract][Full Text] [Related]
22. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
23. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
[TBL] [Abstract][Full Text] [Related]
24. [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
Zöphel K; Wunderlich G; Koch R; Franke WG
Nuklearmedizin; 2000; 39(4):113-20. PubMed ID: 10919162
[TBL] [Abstract][Full Text] [Related]
25. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
[TBL] [Abstract][Full Text] [Related]
26. [Radioreceptor assay of TSH].
Torizuka K; Konishi J; Endo K; Ikekubo K; Mori T
Nihon Rinsho; 1976; 34(3):471-6. PubMed ID: 778435
[No Abstract] [Full Text] [Related]
27. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies.
Filetti S; Foti D; Costante G; Rapoport B
J Clin Endocrinol Metab; 1991 May; 72(5):1096-101. PubMed ID: 2022709
[TBL] [Abstract][Full Text] [Related]
28. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
Macchia E; Fenzi GF; Monzani F; Bartalena L; Lippi F; Aloisio V; Cupini C; Baschieri L; Pinchera A
J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
[TBL] [Abstract][Full Text] [Related]
29. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
30. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
[TBL] [Abstract][Full Text] [Related]
31. [Topics on immunogenic regions in TSH receptors for thyroid disease].
Murakami M; Mori M
Rinsho Byori; 1993 Feb; 41(2):128-35. PubMed ID: 7689665
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
33. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
34. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
35. Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.
Kotulla P; Schleusener H
J Endocrinol Invest; 1981; 4(2):155-60. PubMed ID: 6268690
[TBL] [Abstract][Full Text] [Related]
36. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
37. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
38. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
40. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
